MIROCALS consortium is formed by 12 organisations in the EU to conduct a phase II Proof of Concept / Proof of Mechanism Clinical Trial aiming to test the interleukin-2 (IL-2) as treatment for amyotrophic lateral sclerosis (ALS).

The science of the project is coordinated by Dr Gilbert Bensimon of the University Hospital of Nimes (France) which is the trial sponsor, and Professor P. Nigel Leigh of the Brighton and Sussex Medical School (UK).

Around them, the MIROCALS consortium brings together a strong partnership of: leading scientists and clinicians from six European laboratories in France, Italy, Sweden and UK; two clinical research organisations for professional biobanking and trial regulatory-compliant monitoring; the MND Association one of the most active patients’ associations in the field of neurodegeneration worldwide and an EU project management company.

MIROCALS is a 4-year collaborative research project started in September 2015 and supported by the European Union’s Horizon 2020 research and innovation Programme.

 

Logo CHU Inserm Transfert Logo

University Hospital of Nimes
Nîmes, France

Inserm Transfert
Paris, France

ICON logo jpg original Généthon EN Q

ICON plc
Ireland

Genethon
Evry, France

HumanitasRH 1498139 ny logo en high

Humanitas Research Hospital
Milan, Italy

University of Gothenburg
Sweden

US small pos k tuoslogo key

University of Sussex
UK

University of Sheffield
UK

kingslondon queen mary

King's College London
London, UK

Queen Mary University
London, UK

MNDA ENGLISH PMS BLUE ORANGE  wgk welcome logo

Motor Neurone Disease Association
UK

WGK Consultancy Ltd
UK

News

7th ExCom, Autumn 2019

The 7th Executive Committee Meeting will be held next autumn to discuss about the progress since the last meeting and to plan the next activities.

6th ExCom, March 2019

The 6th Executive Committee Meeting took place on 15th March 2019 to discuss about the progress since the last meeting and to plan the next activities.

MIROCALS 2nd General meeting in Milan, June 2018

The last consortium meeting of MIROCALS was held on June 7th and 8th 2018 in Milan to present the progress made since the beginning of the project. 

Read more
europe

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 633413.